Back to search

Article

<i>In silico</i> discovery of pathogenic PD-L1 nsSNVs with aberrant glycosylation and immunotherapy binding

2025-06-19

Abstract excerpt

Immune checkpoint inhibitors (ICIs), particularly anti-PD-L1 monoclonal antibodies, block extracellular interactions between programmed death ligand-1 (PD-L1) and programmed cell death protein-1 (PD-1) to enhance antitumour immunity. Here, we present a streamlined workflow integrating public databases, bioinformatics tools, and in silico molecular dynamics (MD) simulations and in vitro experimental assays to ide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b3d10c98-c542-5b1d-af15-c3cc287be339
DOI
10.1101/2025.06.17.660108
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In silico</i> discovery of pathogenic PD-L1 nsSNVs with aberrant glycosylation and immunotherapy bindingDOI 10.1101/2025.06.17.660108
Select a neighboring publication to make it the new centre.